Triple negative breast cancer (TNBC) is a heterogeneous group of clinically aggressive breast cancers, designated as pathologically negative for estrogen receptor (ER−), progesterone receptor (PR−), and human epidermal growth factor receptor 2 amplification (HER2−). This evidence concerns the gene PGR and breast cancer.